1.Duan JX, Jiao H, Kaizerman J, Stanton T, Evans JW, Lan L, Lorente G, Banica M, Jung D, Wang J et al.. (2008) Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.. J Med Chem, 51 (8):(2412-20). [PMID:18257544][10.1021/op500134e]
2.Hu J, Handisides DR, Van Valckenborgh E, De Raeve H, Menu E, Vande Broek I, Liu Q, Sun JD, Van Camp B, Hart CP et al.. (2010) Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.. Blood, 116 (9):(1524-7). [PMID:20530289][10.1021/op500134e]
3.Weiss GJ, Infante JR, Chiorean EG, Borad MJ, Bendell JC, Molina JR, Tibes R, Ramanathan RK, Lewandowski K, Jones SF et al.. (2011) Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies.. Clin Cancer Res, 17 (9):(2997-3004). [PMID:21415214][10.1021/op500134e]
4.Sun JD, Liu Q, Wang J, Ahluwalia D, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD et al.. (2012) Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.. Clin Cancer Res, 18 (3):(758-70). [PMID:22184053][10.1021/op500134e]
5.Borad MJ, Reddy SG, Bahary N, Uronis HE, Sigal D, Cohn AL, Schelman WR, Stephenson Jr J, Chiorean EG, Rosen PJ et al.. (2015) Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.. J Clin Oncol, 33 (13):(1475-81). [PMID:25512461][10.1021/op500134e]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
A2206315